Six-month preclinical data from trials of a Xeltis bioabsorbable aortic conduit were presented at the 2016 scientific meeting of the International Society for Applied Cardiovascular Biology (ISACB). The data was presented by Prof. Frederick Schoen, M.D., Ph.D., senior pathologist and executive vice chairman, Department of Pathology at Brigham and Women’s Hospital, and professor of pathology and health sciences and technology, Harvard Medical School.

Technological and administrative obstacles are significantly cutting into available time for physicians to engage with patients. Nearly half a physician’s office day is now filled by data entry into electronic medical records (EHRs) and administrative desk work, according to a new time-motion study conducted by experts at the American Medical Association (AMA) and Dartmouth-Hitchcock healthcare system. The study results were published in the Annals of Internal Medicine.

September 7, 2016 — Toshiba America Medical Systems Inc. announced that its Aplio 500 Platinum ultrasound system will be used during a live case following the International Contrast Ultrasound Society (ICUS) Bubbles Conference, Sept. 8-9 in Chicago. The demonstration is meant to show the benefits of the recent U.S.

September 5, 2016 — Lombard Medical Inc., a company focused on endovascular aneurysm repair (EVAR) of abdominal aortic aneurysms (AAAs), reported Aug. 22 is was closing its U.S. operations to focus on more profitable markets overseas. This was a key component of the company’s significant operational restructuring and the exploration of strategic alternatives do to poor financial reports.